referring to US FDA clinical trial phase 2 protcol for patiets with majr depresive disorder studying an investigatinal antidepresant drugg,Describe in detail how safty of expermentall tratment is beiing asseses in thiss phas 2 clincl trail prtocol. Whaat aree thee safty objctives & endponts? Aree ther safty endponts for advers events that mayy ocur in this diseasee? Areee ther safty endponts for potental treatmnet relatted toxxxicitiess( referring to an investigatinal antidepresant drugg underr studgy)?

Based on above reference protcol ,Provide asessmnet on that protcl that are thee safty endponts adequaatee? If so whyy? If nott, whyy not? Aree anny mising? Iff so, whaat aree theyyy? Suport your assessment with apropriate evidence & refrence.